TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
3 hedge funds and large institutions have $313K invested in TITAN PHARMACEUTICAL INC in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
13% more capital invested
Capital invested by funds: $278K → $313K (+$35K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
+$11K |
| 2 |
DOA
D'Orazio & Associates
Falls Church,
Virginia
|
+$2K |
| 3 |
GS
Gagnon Securities
New York
|
+$172 |
Top Sellers
TTP Hedge Fund Activity: Q1 2016 in Review
3 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q1 2016, worth a combined $313K — up 13% from $278K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TTP positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Vantage Investment Advisors, opening a new position worth an estimated $11K.
- 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q1 2016, up from 1 in Q4 2015.
- Funds reported $313K of TITAN PHARMACEUTICAL INC stock for Q1 2016, up 13% quarter-over-quarter.
- 2 funds opened new TITAN PHARMACEUTICAL INC positions in Q1 2016 and 0 closed out, a net change of +2 holders.
- The largest TITAN PHARMACEUTICAL INC buyer in Q1 2016 was Vantage Investment Advisors, an estimated $11K added.
Based on aggregated 13F filings for Q1 2016.